0938-AU25 202010 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0938 Centers for Medicare & Medicaid Services CMS 0900 Department of Health and Human Services HHS Electronic Prescribing for Controlled Substances (CMS-3394)

This proposed rule would implement section 2003 of the SUPPORT for Patients and Communities Act (SUPPORT Act).  The SUPPORT Act requires that a Schedule II, III, IV, or V controlled substance covered under a Medicare Part D prescription drug plan or Medicare Advantage Prescription Drug Plan (MA/PD) be transmitted in accordance with an electronic prescription drug program beginning January 1, 2021, including when the requirement for Electronic Prescribing for Controlled Substances (EPCS) should be waived, and what (if any) penalties should be imposed on prescribers who do not use EPCS.

]]> Other Significant Previously Published in The Unified Agenda Proposed Rule Stage No No Other None Pub. L. 115-271, sec. 2003 No Notice With Comment 08/04/2020 85 FR 47151 Comment Period End 10/05/2020 NPRM 04/00/2021 No Federal No No No Dan Herrmann Health Insurance Specialist 0938 Centers for Medicare & Medicaid Services CMS 410 786-7827 dan.herrmann@cms.hhs.gov Center for Clinical Standards and Quality, MS: S3-02-01, 7500 Security Boulevard, Baltimore MD 21244